US 11931421
Muscle targeting complexes and formulations for treating myotonic dystrophy
granted A61KA61K2039/505A61K45/06
Quick answer
US patent 11931421 (Muscle targeting complexes and formulations for treating myotonic dystrophy) held by Dyne Therapeutics, Inc. expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Dyne Therapeutics, Inc.
- Grant date
- Tue Mar 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K2039/505, A61K45/06, A61K47/545, A61K47/548